Trump's 200% Drug Tariff Plan Could Impact India's Pharma Industry

22 July 2026 at 7:19 pmHyperFast News

#Trump #drug tariff #India #pharma industry #US trade policy #generic drugs #onshoring manufacturing

Summary

Donald Trump's proposed plan to implement tariffs on generic drug imports, escalating to 200% by 2028, aims to foster US pharmaceutical manufacturing, potentially impacting India's pharma industry despite a two-year grace period.

Trump's 200% Drug Tariff Plan Could Impact India's Pharma Industry

Related news

Select what you want to create

Image Post

Prompt to Post

Audio Post

Video Post

Multi-News Carousel

Upload and Schedule

Blog Post

AI Anchor Video

Newsroom FAQs